<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hoolachan JM</submitter><funding>American Heart Association</funding><funding>NIDDK NIH HHS</funding><funding>NCI NIH HHS</funding><funding>NIH HHS</funding><pagination>e70113</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12602274</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(6)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Mitochondrial homeostasis is vital for optimal skeletal muscle integrity. Mitochondrial quality control (MQC) mechanisms that are essential for maintaining proper functions of mitochondria include mitochondrial biogenesis, dynamics and mitophagy. Previously, Syntaxin 4 (STX4), traditionally considered a cell surface protein known for glucose uptake in skeletal muscle, was also identified at the outer mitochondrial membrane. STX4 enrichment was sufficient to reverse Type 2 diabetes-associated mitochondrial damage in skeletal muscle by inactivation of mitochondrial fission. However, whether STX4 could modulate skeletal muscle mitochondrial homeostasis through MQC mechanisms involving mitochondrial biogenesis or mitophagy remains to be determined.&lt;h4>Methods&lt;/h4>To determin</pubmed_abstract><journal>Journal of cachexia, sarcopenia and muscle</journal><pubmed_title>STX4 Is Indispensable for Mitochondrial Homeostasis in Skeletal Muscle.</pubmed_title><pmcid>PMC12602274</pmcid><funding_grant_id>R01 DK102233</funding_grant_id><funding_grant_id>DK1129712</funding_grant_id><funding_grant_id>R01DK137515</funding_grant_id><funding_grant_id>R01 DK137515</funding_grant_id><funding_grant_id>R56 DK067912</funding_grant_id><funding_grant_id>P30 CA033572</funding_grant_id><funding_grant_id>DK102233</funding_grant_id><funding_grant_id>R01 DK067912</funding_grant_id><funding_grant_id>DK067912</funding_grant_id><funding_grant_id>25CDA1454374</funding_grant_id><pubmed_authors>Jiang L</pubmed_authors><pubmed_authors>Shirihai O</pubmed_authors><pubmed_authors>Hoolachan JM</pubmed_authors><pubmed_authors>Kiperman T</pubmed_authors><pubmed_authors>Pirrotte P</pubmed_authors><pubmed_authors>Thurmond DC</pubmed_authors><pubmed_authors>Merz KE</pubmed_authors><pubmed_authors>Zhou C</pubmed_authors><pubmed_authors>Bloom-Saldana E</pubmed_authors><pubmed_authors>McCown EM</pubmed_authors><pubmed_authors>Hamilton A</pubmed_authors><pubmed_authors>Ma K</pubmed_authors><pubmed_authors>Oh E</pubmed_authors><pubmed_authors>Fueger PT</pubmed_authors><pubmed_authors>Balakrishnan R</pubmed_authors></additional><is_claimable>false</is_claimable><name>STX4 Is Indispensable for Mitochondrial Homeostasis in Skeletal Muscle.</name><description>&lt;h4>Background&lt;/h4>Mitochondrial homeostasis is vital for optimal skeletal muscle integrity. Mitochondrial quality control (MQC) mechanisms that are essential for maintaining proper functions of mitochondria include mitochondrial biogenesis, dynamics and mitophagy. Previously, Syntaxin 4 (STX4), traditionally considered a cell surface protein known for glucose uptake in skeletal muscle, was also identified at the outer mitochondrial membrane. STX4 enrichment was sufficient to reverse Type 2 diabetes-associated mitochondrial damage in skeletal muscle by inactivation of mitochondrial fission. However, whether STX4 could modulate skeletal muscle mitochondrial homeostasis through MQC mechanisms involving mitochondrial biogenesis or mitophagy remains to be determined.&lt;h4>Methods&lt;/h4>To determin</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-05T14:29:46.588Z</modification><creation>2026-05-17T03:12:40.089Z</creation></dates><accession>S-EPMC12602274</accession><cross_references><pubmed>41214862</pubmed><doi>10.1002/jcsm.70113</doi></cross_references></HashMap>